NAS:IART (USA) Also Trade In: Germany
Warning! GuruFocus has detected 1 Severe warning sign with IART. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Integra Lifesciences Holdings Corp () from 1995 to Apr 10 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Integra Lifesciences stock (IART) PE ratio as of Apr 10 2021 is 44.49. More Details
Integra Lifesciences PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Integra Lifesciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.